These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20192802)

  • 1. Substance use in adolescence and psychosis: clarifying the relationship.
    Barkus E; Murray RM
    Annu Rev Clin Psychol; 2010; 6():365-89. PubMed ID: 20192802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics influencing age at onset in psychotic disorders.
    Ongür D; Lin L; Cohen BM
    Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance misuse at presentation to an early psychosis program.
    Van Mastrigt S; Addington J; Addington D
    Soc Psychiatry Psychiatr Epidemiol; 2004 Jan; 39(1):69-72. PubMed ID: 15022049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
    Iyer SN; Boekestyn L; Cassidy CM; King S; Joober R; Malla AK
    Psychol Med; 2008 Aug; 38(8):1147-56. PubMed ID: 18366823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and depressive symptoms in first episode psychosis.
    Romm KL; Rossberg JI; Berg AO; Barrett EA; Faerden A; Agartz I; Andreassen OA; Melle I
    J Nerv Ment Dis; 2010 Jan; 198(1):67-71. PubMed ID: 20061872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of comorbidity 8 years after a first psychotic episode.
    Farrelly S; Harris MG; Henry LP; Purcell R; Prosser A; Schwartz O; Jackson H; McGorry PD
    Acta Psychiatr Scand; 2007 Jul; 116(1):62-70. PubMed ID: 17559602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occurring psychotic and addictive disorders: neurobiology and diagnosis.
    Ross S; Peselow E
    Clin Neuropharmacol; 2012; 35(5):235-43. PubMed ID: 22986797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of substance use on the onset and course of early psychosis.
    Verdoux H; Tournier M; Cougnard A
    Schizophr Res; 2005 Nov; 79(1):69-75. PubMed ID: 16198239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stop Using Stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems.
    Kemp R; Harris A; Vurel E; Sitharthan T
    Australas Psychiatry; 2007 Dec; 15(6):490-3. PubMed ID: 17852064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M; van der Sluis S; de Haan L
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study.
    Addington J; Addington D
    Acta Psychiatr Scand; 2007 Apr; 115(4):304-9. PubMed ID: 17355521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model.
    Cougnard A; Marcelis M; Myin-Germeys I; De Graaf R; Vollebergh W; Krabbendam L; Lieb R; Wittchen HU; Henquet C; Spauwen J; Van Os J
    Psychol Med; 2007 Apr; 37(4):513-27. PubMed ID: 17288646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
    Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
    J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
    Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F
    J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
    Hides L; Kavanagh DJ; Dawe S; Young RM
    Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.